American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S290-S295 , December 2008

The clinical content of preconception care: immunizations as part of preconception care

  • Dean V. Coonrod, MD, MPH

      Affiliations

    • Department of Obstetrics and Gynecology, Maricopa Medical Center, Phoenix, AZ
    • Corresponding Author InformationReprints: Dean V Coonrod, MD, MPH, Chair, Department of Obstetrics and Gynecology, Maricopa Medical Center, OBGYN Dept, 2nd Floor Admin, 2601 E Roosevelt St, Phoenix, AZ 85008
    • ,
  • Brian W. Jack, MD

      Affiliations

    • Department of Family Medicine, Boston University Medical Center, Boston, MA
    • ,
  • Kim A. Boggess, MD

      Affiliations

    • Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
    • ,
  • Richard Long, MD

      Affiliations

    • Department of Family Medicine, Boston University Medical Center, Boston, MA
    • ,
  • Jeanne A. Conry, MD, PhD

      Affiliations

    • Department of Women's Health, Kaiser Permanente, Roseville, CA
    • ,
  • Shanna N. Cox, MSPH

      Affiliations

    • Centers for Disease Control, Division of Reproductive Health/NCCDPHP, Atlanta, GA
    • ,
  • Robert Cefalo, MD, PhD

      Affiliations

    • Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC
    • ,
  • Kam D. Hunter, MD, PhD

      Affiliations

    • Department of Family and Community Medicine, Maricopa Medical Center, Phoenix, AZ
    • ,
  • Albert Pizzica, DO

      Affiliations

    • National Perinatal Association, Harrisburg, PA
    • ,
  • Anne L. Dunlop, MD, MPH

      Affiliations

    • Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, GA

Received 12 June 2008 ,Accepted 29 August 2008.

References 

  1. Centers for Disease Control and Prevention. Prevention of genital human papillomavirus infection. Atlanta: Centers for Disease Control and Prevention; 2004;http://www.cdc.gov/std/HPV/2004HPV%20Report.pdfAccessed March 17, 2008
  2. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol. 2003;101:645–652
  3. Tenti P, Zappatore R, Migliora P, Spinillo A, Belloni C, Carnevali L. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol. 1999;93:475–479
  4. Saslow D, Castle PE, Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007;57:7–28
  5. Crane JM, Delaney T, Hutchens D. Transvaginal ultrasonography in the prediction of preterm birth after treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2006;107:37–44
  6. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1–24
  7. US Preventive Services Task Force. Screening for cervical cancer. http://www.ahrq.gov/clinic/uspstf/uspscerv.htmAccessed October 21, 2008
  8. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342–362
  9. American College of Obstetricians and Gynecologists. ACOG practice bulletin (Cervical Cytology screening. Number 45, August 2003). Int J Gynaecol Obstet. 2003;83:237–247
  10. Sexually transmitted diseases treatment guidelines 2002: Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51:1–78
  11. American College of Obstetricians and Gynecologists ACOG educational bulletin: viral hepatitis in pregnancy. Int J Gynaecol Obstet. 1998;63:195–202
  12. Shepard TH. Catalog of teratogenic agents. Baltimore: Johns Hopkins University Press; 1998;1309
  13. Hieber JP, Dalton D, Shorey J, Combes B. Hepatitis and pregnancy. J Pediatr. 1977;91:545–549
  14. Immunization Action Coalition. Summary of recommendations for adult immunization: item no. P2011. St. Paul (MN): Immunization Action Coalition; 2007;http://www.immunize.org/catg.d/p2011.pdfAccessed March 17, 2008
  15. Paryani SG, Arvin AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med. 1986;314:1542–1546
  16. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–40
  17. Advisory Committee on Immunization Practices (ACIP). Guidelines for vaccinating pregnant women: recommendations of the Advisory Committee on Immunization Practices. Atlanta: Centers for Disease Control and Prevention; 2005;
  18. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics. 1995;95:791–796
  19. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Weekly Rep. 1999;48:1–5
  20. Measles, mumps, and rubella—vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Weekly Rep. 1998;47:1–57
  21. Rubella vaccination during pregnancy: United States, 1971-1988. MMWR Morb Mortal Weekly Rep. 1989;38:289–293
  22. Rubella and congenital rubella syndrome: United States, 1985-1988. MMWR Morb Mortal Weekly Rep. 1989;38:172–188
  23. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–54
  24. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1–40
  25. Englund JA, Mbawuike IN, Hammill H, Holleman MC, Baxter BD, Glezen WP. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis. 1993;168:647–656
  26. Reuman PD, Ayoub EM, Small PA. Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J. 1987;6:398–403
  27. Sumaya CV, Gibbs RS. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis. 1979;140:141–146
  28. Puck JM, Glezen WP, Frank AL, Six HR. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis. 1980;142:844–849
  29. Centers for Disease Control and Prevention. Mercury and vaccines (thimerosal). http://www.cdc.gov/vaccinesafety/concerns/thimerosal.htmAccessed October 21, 2008
  30. Ayoub DM, Yazbak FE. Influenza vaccination during pregnancy: a critical assessment of the recommendations of the Advisory Committee on Immunization Practices (ACIP). J Am Phys Surg. 2006;11:41
  31. American College of Obstetricians and Gynecologists. ACOG committee opinion: influenza vaccination and treatment during pregnancy. Obstet Gynecol. 2004;104:1125–1126
  32. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094–1102
  33. Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–42
  34. Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28:1230–1237
  35. World Health Organization. Progress towards the global elimination of neonatal tetanus, 1990-1998. Weekly Epidemiol Rec. 1999;74:73–80
  36. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Morb Mortal Weekly Rep. 2006;55:1–17
  37. Advisory Committee on Immunization Practices. Prevention of tetanus, diphtheria and pertussis among pregnant women: provisional ACIP recommendations for the use of Tdap vaccine. Atlanta: Centers for Disease Control and Prevention; 2006;http://www.cdc.gov/vaccines/recs/provisional/downloads/tdap-preg.pdfAccessed March 17, 2008
  38. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614–624

 The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

 Conflict of Interest: Dean V. Coonrod, MD, MPH, is a Grant Recipient from the March of Dimes Arizona Chapter to develop an internatal Care Clinic and has funding from CMS (#1HOCMS030207 101) working on compliance with the 6 week postpartum visit as a strategy to improve preconception care. Brian W. Jack, MD; Kim A. Boggess, MD; Richard Long, MD; Jeanne A. Conry, MD, PhD, Shanna N. Cox, MSPH; Robert Cefalo, MD, PhD; Kam D. Hunter, MD, PhD; Albert Pizzica, DO; and Anne L. Dunlop, MD, MPH have no conflict of interest including grants, honoraria, advisory board membership, or share holdings.

PII: S0002-9378(08)01030-2

doi: 10.1016/j.ajog.2008.08.061

American Journal of Obstetrics & Gynecology
Volume 199, Issue 6, Supplement B , Pages S290-S295 , December 2008

Article Tools